Drug-class overview:@0.657199:0.039086:0.902803:0.039086:0.902803:0.019651:0.657199:0.019651:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
27:@0.950592:0.038665:0.976698:0.038665:0.976698:0.018632:0.950592:0.018632:0.000000:0.000000
Drug-class overview:@0.981851:0.292741:0.981851:0.109337:0.953582:0.109337:0.953582:0.292741:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS :@0.216640:0.974259:0.820834:0.974259:0.820834:0.960936:0.216640:0.960936:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.820834:0.974259:0.824580:0.974259:0.824580:0.960936:0.820834:0.960936:0.000000
VOLUME 1:@0.824751:0.974259:0.906065:0.974259:0.906065:0.959690:0.824751:0.959690:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
fibrillation. Conditions where sudden variations :@0.096970:0.096562:0.479951:0.096562:0.479951:0.081574:0.096970:0.081574:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
in  light  intensity  may  occur    Concomitant :@0.096970:0.112437:0.479970:0.112437:0.479970:0.097449:0.096970:0.097449:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.352990:0.111922:0.361803:0.111922:0.361803:0.097237:0.352990:0.097237:0.000000
antipsychotics and tricyclic antidepressants  :@0.096970:0.128312:0.479970:0.128312:0.479970:0.113324:0.096970:0.113324:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096970:0.143672:0.105783:0.143672:0.105783:0.128987:0.096970:0.128987:0.000000
 Concomitant amiodarone   Possible downward :@0.105783:0.144187:0.479990:0.144187:0.479990:0.129199:0.105783:0.129199:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.313196:0.143672:0.322009:0.143672:0.322009:0.128987:0.313196:0.128987:0.000000
dose  titration  of  ivabradine  with  moderate :@0.096989:0.160062:0.479951:0.160062:0.479951:0.145074:0.096989:0.145074:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
CYP3a4 inhibitors.:@0.096989:0.176083:0.236920:0.176083:0.236920:0.161094:0.096989:0.161094:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Drug interactions::@0.096989:0.196562:0.251948:0.196562:0.251948:0.180171:0.096989:0.180171:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1 :@0.251927:0.190784:0.260419:0.190784:0.260419:0.181228:0.251927:0.181228:0.000000:0.000000
CYP3a4 inhibitors increase plasma concentration :@0.096970:0.212590:0.479951:0.212590:0.479951:0.197602:0.096970:0.197602:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096970:0.228095:0.105783:0.228095:0.105783:0.213411:0.096970:0.213411:0.000000
 CYP3a4 inducers decrease plasma concentration :@0.105783:0.228611:0.479951:0.228611:0.479951:0.213622:0.105783:0.213622:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096970:0.244115:0.105783:0.244115:0.105783:0.229431:0.096970:0.229431:0.000000
 Grapefruit juice increases exposure   Qt :@0.105783:0.244631:0.479970:0.244631:0.479970:0.229643:0.105783:0.229643:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.431306:0.244115:0.440119:0.244115:0.440119:0.229431:0.431306:0.229431:0.000000
prolongation of quinidine, disopyramide, bepridil, :@0.096970:0.260652:0.479990:0.260652:0.479990:0.245663:0.096970:0.245663:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
sotalol and ibutilide exacerbated.:@0.096970:0.276672:0.350546:0.276672:0.350546:0.261684:0.096970:0.261684:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
REfEREnCES:@0.097162:0.308713:0.209807:0.308713:0.209807:0.292323:0.097162:0.292323:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1.   Snyman  Jr.  anti-anginal  agents. :@0.096970:0.323055:0.357862:0.323055:0.357862:0.309732:0.096970:0.309732:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Monthly Index of :@0.361317:0.323055:0.478859:0.323055:0.478859:0.309967:0.361317:0.309967:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Medical Specialities.:@0.127278:0.337754:0.255801:0.337754:0.255801:0.324666:0.127278:0.324666:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2011;51(2):142-8.:@0.255801:0.337754:0.374454:0.337754:0.374454:0.324431:0.255801:0.324431:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2.   daiber a, Wenzel P, oelze M, Münzel t. new insights :@0.096970:0.352453:0.479509:0.352453:0.479509:0.339130:0.096970:0.339130:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
into bioactivation of organic nitrates, nitrate :@0.127278:0.367152:0.479491:0.367152:0.479491:0.353829:0.127278:0.353829:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
tolerance and cross-tolerance. :@0.127278:0.381851:0.342297:0.381851:0.342297:0.368528:0.127278:0.368528:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Clinical Research in :@0.345838:0.381851:0.478824:0.381851:0.478824:0.368763:0.345838:0.368763:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Cardiology.:@0.127278:0.396550:0.200519:0.396550:0.200519:0.383462:0.127278:0.383462:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2008;97(1):12-20.:@0.200519:0.396550:0.319172:0.396550:0.319172:0.383227:0.200519:0.383227:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3.   elkayam u, Karaalp IS, Wani or, tummala P, akhter :@0.096970:0.411249:0.479509:0.411249:0.479509:0.397926:0.096970:0.397926:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
MW. the role of organic nitrates in the treatment :@0.127261:0.425949:0.479474:0.425949:0.479474:0.412625:0.127261:0.412625:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of heart failure. :@0.127261:0.440648:0.237157:0.440648:0.237157:0.427324:0.127261:0.427324:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Progress in Cardiovascular Diseases.:@0.239449:0.440648:0.475746:0.440648:0.475746:0.427560:0.239449:0.427560:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475746:0.440648:0.479491:0.440648:0.479491:0.427324:0.475746:0.427324:0.000000
1999;41(4):255-64.:@0.127261:0.455347:0.250515:0.455347:0.250515:0.442023:0.127261:0.442023:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
4.   Steg PG, tchetche d. Pharmacologic management :@0.096952:0.470046:0.479491:0.470046:0.479491:0.456723:0.096952:0.456723:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of stable angina: role of ivabradine. :@0.127261:0.484745:0.372948:0.484745:0.372948:0.471422:0.127261:0.471422:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
European Heart :@0.373239:0.484745:0.478824:0.484745:0.478824:0.471657:0.373239:0.471657:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Journal Supplements.:@0.127261:0.499444:0.266918:0.499444:0.266918:0.486356:0.127261:0.486356:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2006;8(suppl d):d16-d23.:@0.266918:0.499444:0.443795:0.499444:0.443795:0.486121:0.266918:0.486121:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5.   Prasad u, Gray d, Purcell H. review of the If selective :@0.096952:0.514143:0.479491:0.514143:0.479491:0.500820:0.096952:0.500820:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
channel inhibitor ivabradine in the treatment :@0.127278:0.528842:0.479543:0.528842:0.479543:0.515519:0.127278:0.515519:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of chronic stable angina. :@0.127278:0.543541:0.320284:0.543541:0.320284:0.530218:0.127278:0.530218:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Advances  in  Therapy. :@0.327930:0.543541:0.478824:0.543541:0.478824:0.530453:0.327930:0.530453:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2009;26(2):127-37.:@0.127278:0.558240:0.250532:0.558240:0.250532:0.544917:0.127278:0.544917:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
otHer vasoDilators:@0.097226:0.591910:0.357435:0.591910:0.357435:0.570355:0.097226:0.570355:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
alprostadil:@0.096970:0.619938:0.218941:0.619938:0.218941:0.598383:0.096970:0.598383:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
alprostadil is a prostaglandin  e1 agonist, which :@0.096970:0.634860:0.479970:0.634860:0.479970:0.619871:0.096970:0.619871:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
has numerous effects on blood flow.  alprostadil :@0.096970:0.650880:0.479971:0.650882:0.479971:0.635893:0.096970:0.635892:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1 :@0.380182:0.645097:0.388114:0.645097:0.388114:0.636359:0.380182:0.636359:0.000000:0.000000
causes vasodilation by acting directly on the :@0.096970:0.666902:0.479952:0.666902:0.479952:0.651914:0.096970:0.651914:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
vascular and ductus arteriosus smooth muscle, :@0.096970:0.682923:0.479971:0.682923:0.479971:0.667934:0.096970:0.667934:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
preventing or reversing the closure of the ductus :@0.096970:0.698943:0.480009:0.698943:0.480009:0.683955:0.096970:0.683955:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
arteriosus, increasing pulmonary or systemic :@0.096970:0.714964:0.479990:0.714964:0.479990:0.699975:0.096970:0.699975:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
blood flow.  :@0.096970:0.730984:0.202438:0.730993:0.202438:0.716004:0.096970:0.715996:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1,2 :@0.182867:0.725208:0.198224:0.725208:0.198224:0.716470:0.182867:0.716470:0.000000:0.000000:0.000000:0.000000
Indications:  :@0.096971:0.751471:0.218877:0.751476:0.218877:0.735085:0.096971:0.735081:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1, 3:@0.197355:0.745691:0.214991:0.745691:0.214991:0.736135:0.197355:0.736135:0.000000:0.000000:0.000000:0.000000
Palliative  therapy  to temporarily maintain :@0.096977:0.767496:0.479977:0.767496:0.479977:0.752507:0.096977:0.752507:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
patency of ductus ateriosus in neonates having :@0.096977:0.783517:0.479997:0.783517:0.479997:0.768528:0.096977:0.768528:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
ductus-dependent congenital heart defects until :@0.096977:0.799537:0.479958:0.799537:0.479958:0.784548:0.096977:0.784548:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
corrective or palliative surgery can be performed :@0.096977:0.815558:0.479997:0.815558:0.479997:0.800569:0.096977:0.800569:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475763:0.815558:0.479977:0.815558:0.479977:0.800569:0.475763:0.800569:0.000000
:@0.096977:0.831062:0.105790:0.831062:0.105790:0.816378:0.096977:0.816378:0.000000
 erectile dysfunction:@0.105790:0.831578:0.261153:0.831578:0.261153:0.816590:0.105790:0.816590:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage:   :@0.096977:0.852057:0.180396:0.852069:0.180396:0.835678:0.096977:0.835666:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3:@0.166396:0.846285:0.172622:0.846285:0.172622:0.836729:0.166396:0.836729:0.000000
0.1 mg/kg/min by continuous Iv infusion until :@0.096961:0.868090:0.479942:0.868090:0.479942:0.853101:0.096961:0.853101:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
desired response is achieved. decrease to lowest :@0.096961:0.884110:0.479961:0.884110:0.479961:0.869122:0.096961:0.869122:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
maintenance dose :@0.096961:0.900131:0.243876:0.900131:0.243876:0.885142:0.096961:0.885142:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications:  :@0.096961:0.920609:0.267134:0.920618:0.267134:0.904227:0.096961:0.904218:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3 :@0.254755:0.914834:0.263248:0.914834:0.263248:0.905278:0.254755:0.905278:0.000000:0.000000
Hyaline membrane disease :@0.096974:0.936639:0.308736:0.936639:0.308736:0.921650:0.096974:0.921650:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Side effects:  :@0.524251:0.096560:0.637570:0.096562:0.637570:0.080172:0.524251:0.080169:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3:@0.627457:0.090778:0.633683:0.090778:0.633683:0.081222:0.627457:0.081222:0.000000
Flushing   bradycardia   Hypotension  tachycardia :@0.524251:0.112027:0.907252:0.112027:0.907252:0.097039:0.524251:0.097039:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.591349:0.111511:0.600162:0.111511:0.600162:0.096827:0.591349:0.096827:0.000000
:@0.693026:0.111511:0.701839:0.111511:0.701839:0.096827:0.693026:0.096827:0.000000
:@0.804709:0.111511:0.813522:0.111511:0.813522:0.096827:0.804709:0.096827:0.000000
:@0.524251:0.126976:0.533064:0.126976:0.533064:0.112292:0.524251:0.112292:0.000000
 Cardiac arrest   oedema   CHF   Hyperaemia :@0.533064:0.127492:0.907271:0.127492:0.907271:0.112504:0.533064:0.112504:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.652117:0.126976:0.660930:0.126976:0.660930:0.112292:0.652117:0.112292:0.000000
:@0.740709:0.126976:0.749522:0.126976:0.749522:0.112292:0.740709:0.112292:0.000000
:@0.794607:0.126976:0.803420:0.126976:0.803420:0.112292:0.794607:0.112292:0.000000
 :@0.903038:0.127492:0.907252:0.127492:0.907252:0.112504:0.903038:0.112504:0.000000
:@0.524251:0.142441:0.533064:0.142441:0.533064:0.127757:0.524251:0.127757:0.000000
 Pneumopericardium   Second-degree heart :@0.533064:0.142957:0.907252:0.142957:0.907252:0.127969:0.533064:0.127969:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.713308:0.142441:0.722121:0.142441:0.722121:0.127757:0.713308:0.127757:0.000000
block   Shock    right ventricular infundibulum :@0.524251:0.158422:0.907271:0.158422:0.907271:0.143433:0.524251:0.143433:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.573589:0.157906:0.582402:0.157906:0.582402:0.143222:0.573589:0.143222:0.000000
:@0.643958:0.157906:0.652771:0.157906:0.652771:0.143222:0.643958:0.143222:0.000000
spasm    ventricular  fibrillation    ventricular :@0.524270:0.173887:0.907310:0.173887:0.907310:0.158898:0.524270:0.158898:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.588117:0.173371:0.596930:0.173371:0.596930:0.158687:0.588117:0.158687:0.000000
:@0.798571:0.173371:0.807384:0.173371:0.807384:0.158687:0.798571:0.158687:0.000000
hypertrophy :@0.524309:0.189352:0.624100:0.189352:0.624100:0.174363:0.524309:0.174363:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.635338:0.188836:0.644151:0.188836:0.644151:0.174152:0.635338:0.174152:0.000000
  Fever :@0.644151:0.189352:0.705034:0.189352:0.705034:0.174363:0.644151:0.174363:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.716290:0.188836:0.725103:0.188836:0.725103:0.174152:0.716290:0.174152:0.000000
  apnoea :@0.725103:0.189352:0.805267:0.189352:0.805267:0.174363:0.725103:0.174363:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.816505:0.188836:0.825318:0.188836:0.825318:0.174152:0.816505:0.174152:0.000000
  Seizures :@0.825318:0.189352:0.907310:0.189352:0.907310:0.174363:0.825318:0.174363:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903096:0.189352:0.907310:0.189352:0.907310:0.174363:0.903096:0.174363:0.000000
:@0.524309:0.204301:0.533122:0.204301:0.533122:0.189616:0.524309:0.189616:0.000000
  Cerebral  bleeding    neck  hyperextension :@0.533122:0.204817:0.907310:0.204817:0.907310:0.189828:0.533122:0.189828:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.708478:0.204301:0.717291:0.204301:0.717291:0.189616:0.708478:0.189616:0.000000
 :@0.903096:0.204817:0.907310:0.204817:0.907310:0.189828:0.903096:0.189828:0.000000
:@0.524309:0.219766:0.533122:0.219766:0.533122:0.205081:0.524309:0.205081:0.000000
  Hyper  irritation    Hypothermia    Jitteriness :@0.533122:0.220282:0.907329:0.220282:0.907329:0.205293:0.533122:0.205293:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.676362:0.219766:0.685175:0.219766:0.685175:0.205081:0.676362:0.205081:0.000000
:@0.808077:0.219766:0.816890:0.219766:0.816890:0.205081:0.808077:0.205081:0.000000
 :@0.903115:0.220282:0.907329:0.220282:0.907329:0.205293:0.903115:0.205293:0.000000
:@0.524328:0.235231:0.533141:0.235231:0.533141:0.220546:0.524328:0.220546:0.000000
 lethargy   Microcephaly   Stiffness   bradypnoea, :@0.533141:0.235747:0.907367:0.235747:0.907367:0.220758:0.533141:0.220758:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.604165:0.235231:0.612978:0.235231:0.612978:0.220546:0.604165:0.220546:0.000000
:@0.720620:0.235231:0.729433:0.235231:0.729433:0.220546:0.720620:0.220546:0.000000
:@0.796704:0.235231:0.805517:0.235231:0.805517:0.220546:0.796704:0.220546:0.000000
tachypnoea   bronchial wheezing, pneumothorax :@0.524347:0.251211:0.907329:0.251211:0.907329:0.236223:0.524347:0.236223:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.618751:0.250695:0.627564:0.250695:0.627564:0.236011:0.618751:0.236011:0.000000
and:@0.524347:0.266676:0.553865:0.266676:0.553865:0.251688:0.524347:0.251688:0.000000:0.000000:0.000000
respiratory:@0.581517:0.266676:0.663335:0.266676:0.663335:0.251688:0.581517:0.251688:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
depression:@0.690987:0.266676:0.775134:0.266676:0.775134:0.251688:0.690987:0.251688:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
or:@0.802785:0.266676:0.818698:0.266676:0.818698:0.251688:0.802785:0.251688:0.000000:0.000000
distress :@0.846350:0.266676:0.907348:0.266676:0.907348:0.251688:0.846350:0.251688:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524347:0.281625:0.533160:0.281625:0.533160:0.266941:0.524347:0.266941:0.000000
  diarrhoea  and  gastric regurgitation    biliary :@0.533160:0.282141:0.907367:0.282141:0.907367:0.267153:0.533160:0.267153:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.839115:0.281625:0.847928:0.281625:0.847928:0.266941:0.839115:0.266941:0.000000
atresia and hyperbilirubinaemia    disseminated :@0.524367:0.297606:0.907367:0.297606:0.907367:0.282617:0.524367:0.282617:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.781753:0.297090:0.790566:0.297090:0.790566:0.282406:0.781753:0.282406:0.000000
intravascular:@0.524367:0.313071:0.620848:0.313071:0.620848:0.298082:0.524367:0.298082:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
coagulation:@0.646594:0.313071:0.738169:0.313071:0.738169:0.298082:0.646594:0.298082:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.763915:0.312555:0.772728:0.312555:0.772728:0.297871:0.763915:0.297871:0.000000
Hypochromic:@0.798475:0.313071:0.903153:0.313071:0.903153:0.298082:0.798475:0.298082:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
anaemia    thrombocytopenia    renal failure :@0.524367:0.328536:0.907387:0.328536:0.907387:0.313547:0.524367:0.313547:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.601837:0.328020:0.610650:0.328020:0.610650:0.313336:0.601837:0.313336:0.000000
:@0.781522:0.328020:0.790335:0.328020:0.790335:0.313336:0.781522:0.313336:0.000000
 :@0.903173:0.328536:0.907387:0.328536:0.907387:0.313547:0.903173:0.313547:0.000000
:@0.524386:0.343485:0.533199:0.343485:0.533199:0.328800:0.524386:0.328800:0.000000
 Polycystic kidneys   Sepsis   Peritonitis   Hypo- or :@0.533199:0.344001:0.907406:0.344001:0.907406:0.329012:0.533199:0.329012:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.674361:0.343485:0.683174:0.343485:0.683174:0.328800:0.674361:0.328800:0.000000
:@0.735706:0.343485:0.744519:0.343485:0.744519:0.328800:0.735706:0.328800:0.000000
:@0.825587:0.343485:0.834400:0.343485:0.834400:0.328800:0.825587:0.328800:0.000000
hyperkalaemia   Hypoglycaemia   tachyphylaxis:@0.524405:0.359466:0.895360:0.359466:0.895360:0.344477:0.524405:0.344477:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.641033:0.358950:0.649846:0.358950:0.649846:0.344265:0.641033:0.344265:0.000000
:@0.778020:0.358950:0.786833:0.358950:0.786833:0.344265:0.778020:0.344265:0.000000
Special precautions:  :@0.524386:0.379389:0.709049:0.379307:0.709049:0.362916:0.524386:0.362998:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3 :@0.696670:0.373523:0.705163:0.373523:0.705163:0.363967:0.696670:0.363967:0.000000:0.000000
bleeding tendencies   Monitor arterial pressure :@0.524245:0.394772:0.907246:0.394772:0.907246:0.379783:0.524245:0.379783:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.692116:0.394256:0.700929:0.394256:0.700929:0.379572:0.692116:0.379572:0.000000
:@0.524245:0.409721:0.533058:0.409721:0.533058:0.395037:0.524245:0.395037:0.000000
  ventilation    Cortical proliferation of long :@0.533058:0.410237:0.907227:0.410237:0.907227:0.395248:0.533058:0.395248:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.640335:0.409721:0.649148:0.409721:0.649148:0.395037:0.640335:0.395037:0.000000
bones with long-term infusion   Gastric outlet :@0.524245:0.425556:0.907246:0.425556:0.907246:0.410568:0.524245:0.410568:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.779034:0.425040:0.787847:0.425040:0.787847:0.410356:0.779034:0.410356:0.000000
obstruction secondary to antral hyperplasia:@0.524245:0.440876:0.857139:0.440876:0.857139:0.425887:0.524245:0.425887:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
nimodipine:@0.524242:0.469278:0.655501:0.469278:0.655501:0.447723:0.524242:0.447723:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
nimodipine is a dihydropyridine CCb with a short :@0.524242:0.483489:0.907185:0.483489:0.907185:0.468500:0.524242:0.468500:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
duration of action.:@0.524242:0.498808:0.664962:0.498808:0.664962:0.483819:0.524242:0.483819:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Indications::@0.524242:0.518586:0.624629:0.518586:0.624629:0.502195:0.524242:0.502195:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.624627:0.512791:0.630854:0.512791:0.630854:0.503235:0.624627:0.503235:0.000000
Prophylaxis:@0.524242:0.533889:0.610679:0.533889:0.610679:0.518900:0.524242:0.518900:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
and:@0.634231:0.533889:0.663749:0.533889:0.663749:0.518900:0.634231:0.518900:0.000000:0.000000:0.000000
treatment:@0.687321:0.533889:0.764098:0.533889:0.764098:0.518900:0.687321:0.518900:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of:@0.787651:0.533889:0.802930:0.533889:0.802930:0.518900:0.787651:0.518900:0.000000:0.000000
ischaemic:@0.826501:0.533889:0.903029:0.533889:0.903029:0.518900:0.826501:0.518900:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
neurological deficits caused by cerebral :@0.524242:0.549208:0.907223:0.549208:0.907223:0.534220:0.524242:0.534220:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
vasospasm following subarachnoid haemorrhage :@0.524242:0.564528:0.907262:0.564528:0.907262:0.549539:0.524242:0.549539:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of aneurysmal origin:@0.524242:0.579847:0.681741:0.579847:0.681741:0.564858:0.524242:0.564858:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage::@0.524242:0.599625:0.593668:0.599625:0.593668:0.583234:0.524242:0.583234:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5:@0.593668:0.593818:0.599894:0.593818:0.599894:0.584262:0.593668:0.584262:0.000000
Iv infusion: For the first two hours infuse 1 mg :@0.524242:0.614916:0.907204:0.614916:0.907204:0.599927:0.524242:0.599927:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
each hour, increase to 2 mg/hour after two :@0.524242:0.630235:0.907281:0.630235:0.907281:0.615246:0.524242:0.615246:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
hours provided  no increase in  bP is observed :@0.524242:0.645554:0.907281:0.645554:0.907281:0.630566:0.524242:0.630566:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524242:0.660358:0.533055:0.660358:0.533055:0.645674:0.524242:0.645674:0.000000
 Patients with body mass less than 70 kg or :@0.533055:0.660874:0.907243:0.660874:0.907243:0.645885:0.533055:0.645885:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
unstable  bP start at a dose of 0.5 mg or less if :@0.524242:0.676193:0.907166:0.676193:0.907166:0.661205:0.524242:0.661205:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
necessary    oral: Follow Iv administration  60 :@0.524242:0.691513:0.907281:0.691513:0.907281:0.676524:0.524242:0.676524:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.610486:0.690997:0.619299:0.690997:0.619299:0.676312:0.610486:0.676312:0.000000
mg every 4 hours for 21 days   total dose: 360 :@0.524261:0.706832:0.907243:0.706832:0.907243:0.691843:0.524261:0.691843:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.768659:0.706316:0.777472:0.706316:0.777472:0.691632:0.768659:0.691632:0.000000
mg/d   Prophylactic administration: Start therapy :@0.524261:0.722151:0.907262:0.722151:0.907262:0.707163:0.524261:0.707163:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.572271:0.721635:0.581084:0.721635:0.581084:0.706951:0.572271:0.706951:0.000000
no later than 4 days after haemorrhage and :@0.524280:0.737471:0.907281:0.737471:0.907281:0.722482:0.524280:0.722482:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
continue during period of maximum vasospasm. :@0.524280:0.752790:0.907262:0.752790:0.907262:0.737801:0.524280:0.737801:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
If  haemorrhage  source  is  treated  surgically, :@0.524280:0.768109:0.907243:0.768109:0.907243:0.753121:0.524280:0.753121:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
continue Iv treatment for 5 days post-operatively, :@0.524280:0.783429:0.907320:0.783429:0.907320:0.768440:0.524280:0.768440:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
then continue with oral treatment for a further 7 :@0.524280:0.798748:0.907339:0.798748:0.907339:0.783760:0.524280:0.783760:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
days    therapeutic administration: If ischaemic :@0.524280:0.814068:0.907281:0.814068:0.907281:0.799079:0.524280:0.799079:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.567768:0.813552:0.576581:0.813552:0.576581:0.798867:0.567768:0.798867:0.000000
neurological disturbances caused by vasospasm :@0.524280:0.829387:0.907300:0.829387:0.907300:0.814398:0.524280:0.814398:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
after aneurysmal subarachnoid haemorrhage are :@0.524280:0.844706:0.907262:0.844706:0.907262:0.829718:0.524280:0.829718:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
present, treat as early as possible and continue :@0.524280:0.860026:0.907339:0.860026:0.907339:0.845037:0.524280:0.845037:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
for at least 5 days up to a maximum of 14 days. :@0.524280:0.875345:0.907262:0.875345:0.907262:0.860356:0.524280:0.860356:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Continue  with  oral treatment  to  complete  21-:@0.524280:0.890664:0.903029:0.890664:0.903029:0.875676:0.524280:0.875676:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
day treatment period. If haemorrhage source is :@0.524280:0.905984:0.907243:0.905984:0.907243:0.890995:0.524280:0.890995:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
treated surgically, continue Iv therapy 5 days post-:@0.524280:0.921303:0.903009:0.921303:0.903009:0.906315:0.524280:0.906315:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
operatively:@0.524280:0.936768:0.609293:0.936768:0.609293:0.921779:0.524280:0.921779:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000